Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Hisamitsu Pharmaceutical Co Ltd | HPX | 31. mai 2024 | 21.40 | +1.90 |
Invion Limited | 7C8 | 31. mai 2024 | 0.00 | 0.00 |
Kalbe Farma Tbk | LCLA | 31. mai 2024 | 0.07 | -10.00 |
Kyowa Kirin Co. Ltd. | KY4 | 31. mai 2024 | 15.30 | +2.00 |
Laboratorio Reig Jofre S.A. | FEQ1 | 31. mai 2024 | 2.83 | +1.07 |
LEES PHARM | L1PA | 31. mai 2024 | 0.14 | 0.00 |
LIVZON PHARMA | LP6 | 31. mai 2024 | 3.02 | -0.66 |
Luye Pharma Group Ltd | LUP | 31. mai 2024 | 0.31 | 0.00 |
Mayne Pharma Group Limited | HG6 | 31. mai 2024 | 3.04 | +0.66 |
Merck KGAA | MRKC | 31. mai 2024 | 32.40 | -1.22 |
MGC Pharmaceuticals Ltd | H5O | 31. mai 2024 | 0.21 | 0.00 |
Mochida Pharmaceutical Co. Ltd. | MFY | 31. mai 2024 | 17.30 | +1.76 |
MPH Health Care AG | 93M1 | 31. mai 2024 | 33.80 | -3.98 |
N4 Pharma plc. | 0GO | 31. mai 2024 | 0.00 | 0.00 |
Otsuka Holdings Co.,Ltd. | OS1 | 31. mai 2024 | 37.40 | +2.19 |
Pharmanutra S.p.A. | 761 | 31. mai 2024 | 48.30 | +0.42 |
PHARMASGP HOLDING SE O.N. | PSG | 31. mai 2024 | 22.60 | -1.74 |
Provexis Plc | NZCA | 31. mai 2024 | 0.01 | 0.00 |
Roche Holding AG | RHO6 | 31. mai 2024 | 28.86 | +0.77 |
Santen Pharmaceutical Co. Ltd. | SZD | 31. mai 2024 | 9.45 | -2.07 |
SHANDONG XINHUA | XIN | 31. mai 2024 | 0.64 | -0.78 |
Shield Therapeutics plc | 1JS | 31. mai 2024 | 0.02 | -5.13 |
SHINEWAY PHARM | C1S | 31. mai 2024 | 0.96 | -2.03 |
Shionogi & Co. Ltd. | SH0 | 31. mai 2024 | 40.80 | +0.99 |
SIHUAN PHARM | TEL1 | 31. mai 2024 | 0.06 | 0.00 |
Solasia Pharma K.K. | 9SO | 31. mai 2024 | 0.14 | 0.00 |
Sumitomo Dainippon Pharma Co. Ltd | DPM | 31. mai 2024 | 1.77 | +7.27 |
Takeda Pharmaceutical Co | TKD | 31. mai 2024 | 24.50 | +1.41 |
TILT Holdings Inc | 0T01 | 31. mai 2024 | 0.03 | +3.13 |
Toho Holdings Co. Ltd. | TON | 31. mai 2024 | 22.80 | +1.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.